EHA2026 | What are the latest findings from the phase I CaMMouflage trial evaluating CB-011 in RRMM? episode artwork

EPISODE · Jul 2, 2026 · 6 MIN

EHA2026 | What are the latest findings from the phase I CaMMouflage trial evaluating CB-011 in RRMM?

from Multiple Myeloma Hub

During the European Hematology Association (EHA) 2026 Congress, June 11–14, 2026, Stockholm, SE, the Multiple Myeloma Hub spoke with Binod Dhakal, Medical College of Wisconsin, Milwaukee, US. We asked, What are the latest findings from the phase I CaMMouflage trial evaluating CB-011 in RRMM? This educational resource is independently supported by Caribou Biosciences. All content is developed by SES in collaboration with an expert steering committee. Funders are allowed no influence. Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Jul 2, 2026

Embed this episode

NOW PLAYING

EHA2026 | What are the latest findings from the phase I CaMMouflage trial evaluating CB-011 in RRMM?

0:00 6:26

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Multiple Myeloma Hub?

This episode is 6 minutes long.

When was this Multiple Myeloma Hub episode published?

This episode was published on July 2, 2026.

Can I download this Multiple Myeloma Hub episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!